×
Entrez Id:
54106
Gene Symbol:
TLR9
TLR9
Acute leukemia
0.010
GeneticVariation
BEFREE
<b>Methods</b>: The Therapeutic Advances in Childhood Leukemia and Lymphoma Phase I consortium performed a pilot study on 3 patients with MRD positive acute leukemia after an initial remission on conventional chemotherapy (TACL T2009-008) with the TLR 9 agonist (GNKG168).
31530240
2019
×
Entrez Id:
6687
Gene Symbol:
SPG7
SPG7
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
9970
Gene Symbol:
NR1I3
NR1I3
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
10206
Gene Symbol:
TRIM13
TRIM13
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
653108
Gene Symbol:
CXADRP1
CXADRP1
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
1525
Gene Symbol:
CXADR
CXADR
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
846
Gene Symbol:
CASR
CASR
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
407
Gene Symbol:
ARR3
ARR3
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
5573
Gene Symbol:
PRKAR1A
PRKAR1A
Acute leukemia
0.020
GeneticVariation
BEFREE
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23) -Current Treatment Options. Is There a Role for CAR -T Cell Therapy?
31671855
2019
×
Entrez Id:
3105
Gene Symbol:
HLA-A
HLA-A
Acute leukemia
0.030
AlteredExpression
BEFREE
(2) HLA typing and MLC testing of all four family members revealed sharing of HLA-A ,D and DRw determinants between the parents and pointed to the appearance of suppressor cell activity with the outbreak of the acute leukemia of one sibling.
6453845
1980
×
Entrez Id:
6343
Gene Symbol:
SCT
SCT
Acute leukemia
0.030
Biomarker
BEFREE
577 patients with acute leukemia or myelodysplastic syndrome receiving haplo-SCT were enrolled in the study.
29155367
2018
×
Entrez Id:
2120
Gene Symbol:
ETV6
ETV6
Acute leukemia
0.100
GeneticVariation
BEFREE
Acute leukemias with ETV6 /ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin.
20589932
2010
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute leukemia
0.100
GeneticVariation
BEFREE
Acute leukemia in early age (EAL) is characterized by acquired genetic alterations such as MLL rearrangements (MLL -r).
24564228
2014
×
Entrez Id:
947
Gene Symbol:
CD34
CD34
Acute leukemia
0.100
Biomarker
BEFREE
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10 ).
2459568
1988
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute leukemia
0.100
GeneticVariation
BEFREE
Acute leukemias with KMT2A rearrangements have different prognoses, which depend on the partner gene involved in the translocation.
25892123
2015
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute leukemia
0.100
GeneticVariation
BEFREE
Acute leukemias (AL ) with a Mixed Lineage Leukemia (MLL ) gene rearrangement (MLLr) represent a group of leukemic entities conferring intermediate to adverse prognoses.
30446944
2019
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute leukemia
0.100
GeneticVariation
BEFREE
Acute leukemias harboring KMT2A /MLLT10 fusion: a 10-year experience from a single genomics laboratory.
30707474
2019
×
Entrez Id:
952
Gene Symbol:
CD38
CD38
Acute leukemia
0.090
GeneticVariation
BEFREE
Acute leukemia with t(10 ;11)(p11-p15;q13-q23).
8616782
1996
×
Entrez Id:
2125
Gene Symbol:
EVPL
EVPL
Acute leukemia
0.010
AlteredExpression
BEFREE
Acute leukemias expressing p210 -and p 190-type bcr/abl mRNAs: report of two cases and review of the literature.
8701709
1996
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute leukemia
0.100
GeneticVariation
BEFREE
Acute leukemia with t(4;11)(q21,q23) translocation results from the in-frame fusion of the MLL to the AF4/FEL gene.
9808577
1998
×
Entrez Id:
4299
Gene Symbol:
AFF1
AFF1
Acute leukemia
0.060
GeneticVariation
BEFREE
Acute leukemia with t(4;11)(q21,q23) translocation results from the in-frame fusion of the MLL to the AF4/FEL gene.
9808577
1998
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute leukemia
0.100
Biomarker
BEFREE
MLL -AF1q fusion resulting from t(1;11) in acute leukemia .
10025907
1999
×
Entrez Id:
3815
Gene Symbol:
KIT
KIT
Acute leukemia
0.090
Biomarker
BEFREE
CD117 should be included on a routine basis for the immunophenotypic diagnosis of acute leukemias .
10229319
1999
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute leukemia
0.100
GeneticVariation
BEFREE
MLL gene rearrangements identify a subgroup of acute leukemias with a bad prognosis.
10374852
1999
×
Entrez Id:
5243
Gene Symbol:
ABCB1
ABCB1
Acute leukemia
0.100
AlteredExpression
BEFREE
MDR1 /P-GP expression as a prognostic factor in acute leukemias .
10500774
1999